Open the Trustpilot page of almost any subscription supplement brand, filter by one star and you'll find the same three complaints, over and over:
- "I was charged again after I cancelled."
- "My card was declined but they said my subscription was finished, I never wanted to leave."
- "I signed up for the trial and then got hit with a charge I didn't expect."
Here's what's interesting: most of these aren't complaints about the product. The customer liked the protein powder, the collagen was working. These are billing failures wearing the costume of customer complaints, and they're doing double damage.
First they cost you the revenue. Then they cost you the review score that your next thousand customers will check before buying.
The nutraceuticals industry runs on recurring billing: subscribe-and-save, continuity programs, free trials converting to monthly plans. This is the engine behind the category's growth and it's also why supplement brands lose more revenue to failed payments than almost any other vertical in e-commerce.
Failed payments cost merchants an estimated $157B every year. Supplement brands sit disproportionately inside that number. Here's why, and what the best operators are doing about it.
Challenge #1: The first charge is where subscriptions go to die
Every supplement brand knows the funnel: ad → landing page → trial or intro offer → recurring plan. What fewer brands measure precisely is what happens at the moment of first full charge.
That first charge is the single highest-decline event in the entire subscriber lifecycle. The card was good enough for a $1 trial or a discounted first bottle. But the first full-price recurring charge? That's when issuers get suspicious: new merchant, different amount than the first transaction, a billing descriptor the cardholder may not recognize.
The result: a customer who actively chose your product gets silently dropped before their second shipment, not because they churned, but because a bank algorithm said no.
They never see an error message, you never get a second chance and the revenue just doesn't arrive.
Challenge #2: Every failed renewal is a wasted ad dollar
Supplement brands think hard about CAC. $40 to $120 to acquire a subscriber through Meta and Google is standard in this category. Growth teams optimize creative, landing pages, and offers to the decimal point.
Then a soft decline in month two erases the entire investment. This is the reframe that changes how CFOs and media buyers see payment recovery:
A failed renewal isn't a billing event. It's a marketing loss.
Do the math on your own numbers. If your CAC is $80 and your payback period is three months, every subscriber lost to a payment failure in month two is $80 of ad spend converted into nothing. Multiply by your monthly involuntary churn and you get a number that would never survive a marketing budget review, except it never appears in one, because it's hiding in the billing system.
Recovered payments are recovered ROAS. Same campaigns, same creative, same spend: more of it converting into revenue that actually arrives.
We had strong PSPs and solid approval rates, but there was always a percentage of revenue we couldn't get back. When you're spending heavily to acquire customers, losing them at payment is the worst possible place to leak. Paymend recovers that revenue without us having to touch anything, we just see the revenue land.
Health & Wellness DTC brand's CEO
Challenge #3: Your dunning sequence was never designed for this
Most supplement brands already have a dunning setup: the billing platform retries the card a few times, sends a "please update your payment method" email, and cancels the subscription after a set number of failures.
Here's the uncomfortable truth about that setup: it asks your customer to do the work of fixing your billing problem.
Dunning emails get ignored, update-your-card links get opened on a phone, abandoned at the login screen. Native retry logic re-runs the same transaction, through the same processor, in the same way that just failed, and gets the same answer.
Payment issues cause up to 40% of subscription cancellations. Your dunning sequence catches a fraction of them. The rest get written off as "churn" in a dashboard, where nobody asks whether the customer actually wanted to leave.
Dunning isn't wrong, it's just the last line of a defense that needs more back-up.
What revenue recovery actually changes
A revenue recovery layer sits after your existing payment stack, after your PSP has declined, after your billing platform's retries have run out, after dunning has failed. It takes the transactions everyone else has written off and recovers them.
For supplement brands, that changes three things:
The first charge stops being a cliff. Failed trial-to-paid conversions get recovered in real time, before the customer you paid to acquire disappears. The known drop-off point becomes a recovery point.
Involuntary churn becomes recovered LTV. Renewals that fail on expired cards, insufficient funds, or issuer nerves get rerouted through the optimal recovery path, without the customer lifting a finger, and without breaking the daily habit your product built.
Your review page reflects your product, not your billing. Fewer surprise lapses and failed charges means fewer one-star billing reviews sitting on top of your Trustpilot score, and fewer support tickets that start with "why was I charged."
Because recovery operates as an external layer, nothing about your current setup changes. No migration, no new checkout, no switching PSPs. Brands typically go live in about two weeks, and with a performance-only model, you pay nothing unless revenue is actually recovered.
The numbers behind it
Merchants using post-stack recovery routinely recapture revenue their billing provider had classified as permanently lost. One health & wellness DTC brand recovered $1.9M in revenue that had already been written off. Across our merchant base, Paymend has recovered $150M+ in failed payments, with individual brands recovering up to 14% of previously failed transactions.
For a supplement brand doing $2M/month with a typical decline rate, that's not a rounding error. That's a new best-performing acquisition channel, except the customers were already yours.
Three questions to ask your team this week:
- What's our decline rate on the first full charge after a trial or intro offer?
- How much did we spend acquiring the subscribers we lost to involuntary churn last quarter?
- What happens to a transaction after our final dunning retry fails?
If the answer to the third question is "nothing", that's the gap. That's where the revenue is.
Paymend recovers the payments your billing stack writes off. Performance-only, live in two weeks, no changes to your existing setup.
